Skip to content

Clinical Study on the Analgesic Efficacy of Topical Anesthetic Liquid Dressing After Hemorrhoidectomy

Clinical Study on the Analgesic Efficacy of Topical Anesthetic Liquid Dressing After Hemorrhoidectomy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108400
Enrollment
Unknown
Registered
2025-08-29
Start date
2025-09-10
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain following hemorrhoidectomy

Interventions

Experimental group:Hemorrhoid Liquid Dressing Intervention
Control group:None Hemorrhoid Liquid Dressing Intervention

Sponsors

Yantai Yuhuangding Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged between 18-60 years old with a confirmed diagnosis of hemorrhoids, internal hemorrhoids, external hemorrhoids, or mixed hemorrhoids; 2. Be able to comply with the experimental protocol; 3. Including requirements such as on-time debridement medication follow-up visits; 4. Volunteer to participate in this study and sign the informed consent form; 5. Pain score VAS>=5 points on the day after hemorrhoidectomy.

Exclusion criteria

Exclusion criteria: 1.Persons with psychiatric disorders or conditions impairing reliable pain perception reporting; 2.Recently used other medications that affect pain perception (such as opioid analgesics) not prescribed by a physician post-surgery; 3.Pregnant or lactating women; 4.Other anorectal diseases(Anal fistula, Perianal abscess).

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale (VAS);

Secondary

MeasureTime frame
Pain Catastrophizing Scale (PCS);Verbal Rating Scale (VRS);

Countries

China

Contacts

Public ContactZaiqiu Wang

Yantai Yuhuangding Hospital

wangzaiqiu8@126.com+86 535 6027604

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026